Difference between revisions of "Template:Drugs for treatment of bone diseases"
Jump to navigation
Jump to search
imported>Tom (LT) m (per Template_talk:Medicine_navs#Background_colours, remove unnecessary and confusing background colours using AWB) |
imported>NSH002 (tidy up) |
||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Drugs for treatment of bone diseases |
| − | | title = Drugs for treatment of [[bone disease]]s ([[ATC code M05|M05]]) | + | | title = Drugs for treatment of [[bone disease]]s ([[ATC code M05|M05]]) |
| − | | state = {{{state|autocollapse}}} | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | |listclass = hlist | + | | listclass = hlist |
| − | | group1 = [[Bisphosphonate]]s | + | | group1 = [[Bisphosphonate]]s |
| − | | | + | | list1 = |
* [[Nitrogen]]ous ([[Alendronic acid]] | * [[Nitrogen]]ous ([[Alendronic acid]] | ||
* [[ibandronic acid]] | * [[ibandronic acid]] | ||
| Line 12: | Line 12: | ||
* [[pamidronic acid]] | * [[pamidronic acid]] | ||
* [[risedronic acid]] | * [[risedronic acid]] | ||
| − | * [[zoledronic acid]])< | + | * [[zoledronic acid]])<br />Non-nitrogenous ([[Etidronic acid]] |
* [[clodronic acid]] | * [[clodronic acid]] | ||
* [[tiludronic acid]]) | * [[tiludronic acid]]) | ||
| − | | group2 = [[Bone morphogenetic protein]]s | + | | group2 = [[Bone morphogenetic protein]]s |
| − | | | + | | list2 = |
* [[Bone morphogenetic protein 2|Dibotermin alfa]] | * [[Bone morphogenetic protein 2|Dibotermin alfa]] | ||
* [[Eptotermin alfa]] | * [[Eptotermin alfa]] | ||
| − | | group3 = Other | + | | group3 = Other |
| − | | | + | | list3 = |
* ''Resorption inhibitor'' ([[Ipriflavone]]) | * ''Resorption inhibitor'' ([[Ipriflavone]]) | ||
* [[Aluminium chlorohydrate]] | * [[Aluminium chlorohydrate]] | ||
* ''Dual action bone agent'' ([[Strontium ranelate]]) | * ''Dual action bone agent'' ([[Strontium ranelate]]) | ||
| − | * <br/> ''[[RANKL]] inhibitor'' ([[Denosumab]]) | + | * <br /> ''[[RANKL]] inhibitor'' ([[Denosumab]]) |
* ''[[Cathepsin K]] inhibitor'' ([[Odanacatib]]) | * ''[[Cathepsin K]] inhibitor'' ([[Odanacatib]]) | ||
* [[Calcium]] | * [[Calcium]] | ||
* [[Vitamin D]] | * [[Vitamin D]] | ||
| − | + | | belowstyle = background: transparent; padding: 0px; | |
| − | + | | below = {{Bone and cartilage navs}} | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | | belowstyle = background: transparent; padding: 0px; | ||
| − | | below = {{Bone and cartilage navs}} | ||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | [[Category: | + | [[Category:Drug templates by ATC]] |
| − | |||
</noinclude> | </noinclude> | ||
Revision as of 08:38, 31 March 2015
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Drugs for treatment of bone diseases|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Drugs for treatment of bone diseases|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Drugs for treatment of bone diseases|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.